Mesenchymal stem cells influence monocyte/macrophage phenotype: Regulatory mode and potential clinical applications
Mesenchymal stem cells (MSCs) are pluripotent stem cells derived from a variety of tissues, such as umbilical cord, fat, and bone marrow. Today, MSCs are widely recognized for their prominent anti-inflammatory properties in a variety of acute and chronic inflammatory diseases. In inflammatory diseas...
Saved in:
Published in | Biomedicine & pharmacotherapy Vol. 165; p. 115042 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
France
Elsevier Masson SAS
01.09.2023
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Mesenchymal stem cells (MSCs) are pluripotent stem cells derived from a variety of tissues, such as umbilical cord, fat, and bone marrow. Today, MSCs are widely recognized for their prominent anti-inflammatory properties in a variety of acute and chronic inflammatory diseases. In inflammatory diseases, monocytes/macrophages are an important part of the innate immune response in the body, and the alteration of the inflammatory phenotype plays a crucial role in the secretion of pro-inflammatory/anti-inflammatory factors, the repair of injured sites, and the infiltration of inflammatory cells. In this review, starting from the effect of MSCs on the monocyte/macrophage phenotype, we have outlined in detail the process by which MSCs influence the transformation of the monocyte/macrophage inflammatory phenotype, emphasizing the central role of monocytes/macrophages in MSC-mediated anti-inflammatory and damage site repair. MSCs are phagocytosed by monocytes/macrophages in various physiological states, the paracrine effect of MSCs and mitochondrial transfer of MSCs to macrophages to promote the transformation of monocytes/macrophages into anti-inflammatory phenotypes. We also review the clinical applications of the MSCs-monocytes/macrophages system and describe novel pathways between MSCs and tissue repair, the effects of MSCs on the adaptive immune system, and the effects of energy metabolism levels on monocyte/macrophage phenotypic changes.
[Display omitted]
•Mesenchymal stem cells convert monocytes/macrophages to an anti-inflammatory phenotype in three main ways.•Mesenchymal stem cells contribute to monocyte/macrophage phenotypic transformation through phagocytosis by monocytes/macrophages.•Paracrine actions of mesenchymal stem cells can induce monocytes/macrophages to switch to an anti-inflammatory phenotype.•Mitochondrial transfer from mesenchymal stem cells to macrophages can promote their conversion to an anti-inflammatory phenotype. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 0753-3322 1950-6007 |
DOI: | 10.1016/j.biopha.2023.115042 |